These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 11850838)

  • 1. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells.
    Ala-aho R; Grénman R; Seth P; Kähäri VM
    Oncogene; 2002 Feb; 21(8):1187-95. PubMed ID: 11850838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo.
    Ala-aho R; Ahonen M; George SJ; Heikkilä J; Grénman R; Kallajoki M; Kähäri VM
    Oncogene; 2004 Jul; 23(30):5111-23. PubMed ID: 15094779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.
    Johansson N; Airola K; Grénman R; Kariniemi AL; Saarialho-Kere U; Kähäri VM
    Am J Pathol; 1997 Aug; 151(2):499-508. PubMed ID: 9250162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas.
    Moilanen M; Pirilä E; Grénman R; Sorsa T; Salo T
    J Pathol; 2002 May; 197(1):72-81. PubMed ID: 12081207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate causes the p21/WAF1-mediated G(1)-phase arrest of cell cycle and inhibits matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells.
    Kim CH; Moon SK
    Arch Biochem Biophys; 2005 Mar; 435(2):264-72. PubMed ID: 15708369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
    St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
    Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts.
    Lengyel E; Gum R; Juarez J; Clayman G; Seiki M; Sato H; Boyd D
    Cancer Res; 1995 Feb; 55(4):963-7. PubMed ID: 7850814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associated with activation of extracellular signal-regulated kinase-1,2 and STAT1.
    Ala-aho R; Johansson N; Grénman R; Fusenig NE; López-Otín C; Kähäri VM
    Oncogene; 2000 Jan; 19(2):248-57. PubMed ID: 10645003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways.
    Sheikh MS; Li XS; Chen JC; Shao ZM; Ordonez JV; Fontana JA
    Oncogene; 1994 Dec; 9(12):3407-15. PubMed ID: 7970699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
    Jiang H; Lin J; Su ZZ; Herlyn M; Kerbel RS; Weissman BE; Welch DR; Fisher PB
    Oncogene; 1995 May; 10(9):1855-64. PubMed ID: 7753561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
    Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
    Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.